SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.696-1.1%Jan 14 3:51 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dowman who wrote (11165)12/6/1998 9:00:00 AM
From: FreedomForAll  Read Replies (1) of 14328
 
<As in your 30x scenario, remember to factor in the corporate tax rate of 38% on Trinity's earnings. That is the way any potential corporate acquirer would value this company. A shareholder, who is also buying the business, should use similar methods>

As a shareholder, I do not analyze the company in the same way as if I were buying the whole company and moving it to the US. Neither should any other shareholder. TRIBY is an Irish company and it derives benefits from the lower taxes. These benefits increase the market value.

As a shareholder, I hope other companies do use your logic for acquisitions, because it makes TRIBY less likely to be acquired, and an acquisition would not give me the ten-bagger that TRIBY can be if it stays independent.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News